188 related articles for article (PubMed ID: 11825905)
1. Assembly limits the pharmacological complexity of ATP-sensitive potassium channels.
Giblin JP; Cui Y; Clapp LH; Tinker A
J Biol Chem; 2002 Apr; 277(16):13717-23. PubMed ID: 11825905
[TBL] [Abstract][Full Text] [Related]
2. Sulfonylurea receptors type 1 and 2A randomly assemble to form heteromeric KATP channels of mixed subunit composition.
Chan KW; Wheeler A; Csanády L
J Gen Physiol; 2008 Jan; 131(1):43-58. PubMed ID: 18079561
[TBL] [Abstract][Full Text] [Related]
3. Proximal C-terminal domain of sulphonylurea receptor 2A interacts with pore-forming Kir6 subunits in KATP channels.
Rainbow RD; James M; Hudman D; Al Johi M; Singh H; Watson PJ; Ashmole I; Davies NW; Lodwick D; Norman RI
Biochem J; 2004 Apr; 379(Pt 1):173-81. PubMed ID: 14672537
[TBL] [Abstract][Full Text] [Related]
4. Coassembly of different sulfonylurea receptor subtypes extends the phenotypic diversity of ATP-sensitive potassium (KATP) channels.
Wheeler A; Wang C; Yang K; Fang K; Davis K; Styer AM; Mirshahi U; Moreau C; Revilloud J; Vivaudou M; Liu S; Mirshahi T; Chan KW
Mol Pharmacol; 2008 Nov; 74(5):1333-44. PubMed ID: 18723823
[TBL] [Abstract][Full Text] [Related]
5. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.
Dörschner H; Brekardin E; Uhde I; Schwanstecher C; Schwanstecher M
Mol Pharmacol; 1999 Jun; 55(6):1060-6. PubMed ID: 10347249
[TBL] [Abstract][Full Text] [Related]
6. The N-terminal transmembrane domain (TMD0) and a cytosolic linker (L0) of sulphonylurea receptor define the unique intrinsic gating of KATP channels.
Fang K; Csanády L; Chan KW
J Physiol; 2006 Oct; 576(Pt 2):379-89. PubMed ID: 16887879
[TBL] [Abstract][Full Text] [Related]
7. Random assembly of SUR subunits in K(ATP) channel complexes.
Cheng WW; Tong A; Flagg TP; Nichols CG
Channels (Austin); 2008; 2(1):34-8. PubMed ID: 18690055
[TBL] [Abstract][Full Text] [Related]
8. Differential nucleotide regulation of KATP channels by SUR1 and SUR2A.
Masia R; Enkvetchakul D; Nichols CG
J Mol Cell Cardiol; 2005 Sep; 39(3):491-501. PubMed ID: 15893323
[TBL] [Abstract][Full Text] [Related]
9. Different binding properties and affinities for ATP and ADP among sulfonylurea receptor subtypes, SUR1, SUR2A, and SUR2B.
Matsuo M; Tanabe K; Kioka N; Amachi T; Ueda K
J Biol Chem; 2000 Sep; 275(37):28757-63. PubMed ID: 10893240
[TBL] [Abstract][Full Text] [Related]
10. Syntaxin-1A inhibits cardiac KATP channels by its actions on nucleotide binding folds 1 and 2 of sulfonylurea receptor 2A.
Kang Y; Leung YM; Manning-Fox JE; Xia F; Xie H; Sheu L; Tsushima RG; Light PE; Gaisano HY
J Biol Chem; 2004 Nov; 279(45):47125-31. PubMed ID: 15339904
[TBL] [Abstract][Full Text] [Related]
11. The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide.
Sunaga Y; Gonoi T; Shibasaki T; Ichikawa K; Kusama H; Yano H; Seino S
Eur J Pharmacol; 2001 Nov; 431(1):119-25. PubMed ID: 11716850
[TBL] [Abstract][Full Text] [Related]
12. Hybrid assemblies of ATP-sensitive K+ channels determine their muscle-type-dependent biophysical and pharmacological properties.
Tricarico D; Mele A; Lundquist AL; Desai RR; George AL; Conte Camerino D
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1118-23. PubMed ID: 16418275
[TBL] [Abstract][Full Text] [Related]
13. Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.
Chachin M; Yamada M; Fujita A; Matsuoka T; Matsushita K; Kurachi Y
J Pharmacol Exp Ther; 2003 Mar; 304(3):1025-32. PubMed ID: 12604678
[TBL] [Abstract][Full Text] [Related]
14. Is the molecular composition of K(ATP) channels more complex than originally thought?
Pountney DJ; Sun ZQ; Porter LM; Nitabach MN; Nakamura TY; Holmes D; Rosner E; Kaneko M; Manaris T; Holmes TC; Coetzee WA
J Mol Cell Cardiol; 2001 Aug; 33(8):1541-6. PubMed ID: 11448141
[TBL] [Abstract][Full Text] [Related]
15. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels.
Liu Y; Ren G; O'Rourke B; Marbán E; Seharaseyon J
Mol Pharmacol; 2001 Feb; 59(2):225-30. PubMed ID: 11160857
[TBL] [Abstract][Full Text] [Related]
17. On potential interactions between non-selective cation channel TRPM4 and sulfonylurea receptor SUR1.
Sala-Rabanal M; Wang S; Nichols CG
J Biol Chem; 2012 Mar; 287(12):8746-56. PubMed ID: 22291026
[TBL] [Abstract][Full Text] [Related]
18. H3 domain of syntaxin 1A inhibits KATP channels by its actions on the sulfonylurea receptor 1 nucleotide-binding folds-1 and -2.
Cui N; Kang Y; He Y; Leung YM; Xie H; Pasyk EA; Gao X; Sheu L; Hansen JB; Wahl P; Tsushima RG; Gaisano HY
J Biol Chem; 2004 Dec; 279(51):53259-65. PubMed ID: 15485808
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the trafficking efficiency and functional properties of ATP-sensitive potassium channels through a single amino acid in the sulfonylurea receptor.
Cartier EA; Shen S; Shyng SL
J Biol Chem; 2003 Feb; 278(9):7081-90. PubMed ID: 12496311
[TBL] [Abstract][Full Text] [Related]
20. Cloning of rabbit Kir6.1, SUR2A, and SUR2B: possible candidates for a renal K(ATP) channel.
Brochiero E; Wallendorf B; Gagnon D; Laprade R; Lapointe JY
Am J Physiol Renal Physiol; 2002 Feb; 282(2):F289-300. PubMed ID: 11788443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
